Program Presentations
MassMEDIC's Annual Conference, Annual MedTech Investors Conference and informational programs throughout the year feature presentations conducted by leading medical device industry executives, thought leaders, researchers, policy makers and management experts. The following is a library of presentations and reports from past MassMEDIC programs and events.
March 31, 2011
A New World Order for Health Care: Payment Reform – Accountable Care Organizations-Comparative Effectiveness
Comparative Effectiveness – Implications for MedTech Companies
Randel Richner, Pesident, Neocure Group
Randel Richner, Pesident, Neocure Group
Current Status of Implementaion of the Health Care Reform Law
Stephen H. Cooper, Government Relations Counselor
Stephen H. Cooper, Government Relations Counselor
Healthcare Reform: Implications for the Medical Device Industry
Charles Matthews, Vice President, Boston Healthcare
Charles Matthews, Vice President, Boston Healthcare
March 3, 2011
The Promise of Combination Products
Drug-Device Combination Products
Peter D. Noymer, Ph.D., Vice President, Product R&D, Alexza Pharmaceuticals
Peter D. Noymer, Ph.D., Vice President, Product R&D, Alexza Pharmaceuticals
The IP Landscape for Combination Products
Jason Honeyman, Shareholder, Wolf Greenfield & Sacks, P.C.
Jason Honeyman, Shareholder, Wolf Greenfield & Sacks, P.C.
Regulatory Challenges Facing Combination Products
Mary Beth Henderson, Ph.D., Principal Advisor, Regulatory and Clinical Research Institute (RCRI)
Mary Beth Henderson, Ph.D., Principal Advisor, Regulatory and Clinical Research Institute (RCRI)
December 1, 2010
MassMEDIC FDA Update
News from the FDA New England District
Mutahar Shamsi, Director of Compliance, FDA New England District Office
Mutahar Shamsi, Director of Compliance, FDA New England District Office
Project Management – What We All Need to Know
Bruce Fieggen, Vice President of Project Management and Training, QPharma, Inc.
Bruce Fieggen, Vice President of Project Management and Training, QPharma, Inc.
21 CFR Part 11 Compliance – What’s New
Fred Sperry, Validation Manager, QPharma, Inc.
Fred Sperry, Validation Manager, QPharma, Inc.
510(K) Reform: Partnering With FDA – Process Improvements that Foster Innovation and Benefit Public Health
Sheila Hemeon-Heyer, JD, RAC-Heyer Regulatory Solutions LLC
Sheila Hemeon-Heyer, JD, RAC-Heyer Regulatory Solutions LLC
Update on Regulatory Environment – Europe
Paul Brooks-VP, Healthcare, Americas
Paul Brooks-VP, Healthcare, Americas
September 22, 2010
Product Launch Strategies for MedTech Companies
Putting Your Best Foot Forward for Launch
Susan Posner, Vice President, Health Advances LLC
Susan Posner, Vice President, Health Advances LLC
Taking Control of Your Fuzzy Front End
Sanjeev Wadhwani, Project Management Consultant, Integrated Project Management, Inc.
Sanjeev Wadhwani, Project Management Consultant, Integrated Project Management, Inc.
Breakthrough Product Launches: The Formula for Success
Joan Schneider, author of The NEW Launch Plan - 152 Tips, Tactics and Trends from the Most Memorable New Products
Joan Schneider, author of The NEW Launch Plan - 152 Tips, Tactics and Trends from the Most Memorable New Products
July 27, 2010
How to Access New Financing from MassDevelopment
July 22, 2010
Under EnviroForum
July 15, 2010
MassMEDIC – Israel Working Group
May 25, 2010
Webinar – Health Care Reform Law: Implications for the MedTech Industry
The Health Care Reform Law: Implications for the Medical Device Industry
Linda Bentley, Mintz Levin
Linda Bentley, Mintz Levin
Selected Tax Provisions from the Health Care Reform Act
Rob Noonan, KPMG LLP
Rob Noonan, KPMG LLP
May 4, 2010
The State of MedTech Innovation in An Era of Change: Dealing With Economic, Policy and Cost Containment Pressures
Sharad Rastogi, Director, PRTM
Sharad Rastogi, Director, PRTM
What’s Your MedTech Company’s Innovation IQ?
Bob Lavoie, Vice President, L.E.K. Consulting.
Bob Lavoie, Vice President, L.E.K. Consulting.
April 8, 2010